Section Arrow
AQST.NASDAQ
- Aquestive Therapeutics
Quotes are at least 15-min delayed:2025/12/26 16:33 EST
After Hours
Last
 6.01
+0.02 (+0.33%)
Bid
5.99
Ask
5.99
High 6.01 
Low 5.98 
Volume 27.35K 
Regular Hours (Closed)
Last
 5.99
+0.02 (+0.34%)
Day High 
6.0499 
Prev. Close
5.97 
1-M High
6.735 
Volume 
1.68M 
Bid
5.99
Ask
5.99
Day Low
5.835 
Open
1-M Low
5.61 
Market Cap 
728.36M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.93 
20-SMA 6.09 
50-SMA 6.22 
52-W High 7.55 
52-W Low 2.12 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.70/-0.37
Enterprise Value
765.83M
Balance Sheet
Book Value Per Share
-0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
57.56M
Operating Revenue Per Share
0.39
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.19-0.12-9.16%-- 
After Hours 1.19 0 0.00%
HIMSHims & Hers Health34.31-0.36-1.04%65.13PE
After Hours 34.2182 -0.0918 -0.27%
IXHLIncannex Healthcare0.3988-0.0118-2.87%-- 
After Hours 0.4 +0.0012 +0.30%
TLRYTilray Brands Inc.9.6-0.55-5.42%-- 
After Hours 9.5897 -0.0103 -0.11%
DVAXDynavax Technologies Corp15.38----48.45PE
After Hours 15.37 -0.01 -0.07%
Industry overview quotes are at least 15 minutes delayed
Business Description
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.